Literature DB >> 4401337

Risk with -blocking in bronchial asthma.

J Gaddie, C Skinner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4401337      PMCID： PMC1787674          DOI： 10.1136/bmj.1.5802.749-b

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  3 in total

1.  EFFECT OF A BETA-ADRENERGIC-BLOCKING AGENT, PROPRANOLOL, ON ASTHMATICS.

Authors:  R S MCNEILL
Journal:  Lancet       Date:  1964-11-21       Impact factor: 79.321

2.  Effect of a selectivebeta-adrenergic blocker in preventing falls in arterial oxygen tension following isoprenaline in asthmatic subjects.

Authors:  K N Palmer; W F Hamilton; J S Lge; M L Diament
Journal:  Lancet       Date:  1969-11-22       Impact factor: 79.321

3.  Comparison of the effect of alprenolol and propranolol on specific airway conductance in asthmatic subjects.

Authors:  C K Connolly; J C Batten
Journal:  Br Med J       Date:  1970-05-30
  3 in total
  4 in total

Review 1.  Adverse effects of antihypertensive drugs.

Authors:  F E Husserl; F H Messerli
Journal:  Drugs       Date:  1981-09       Impact factor: 9.546

Review 2.  Adverse effects of beta-adrenergic receptor blocking drugs on respiratory function.

Authors:  H M Beumer
Journal:  Drugs       Date:  1974       Impact factor: 9.546

Review 3.  Beta-adrenergic receptor blocking drugs in hypertension.

Authors:  F O Simpson
Journal:  Drugs       Date:  1974       Impact factor: 9.546

4.  Comparison of the effects of acebutolol (Sectral) and practolol (Eraldin) on airways obstruction in asthmatics.

Authors:  C Skinner; K N Palmer
Journal:  Br J Clin Pharmacol       Date:  1975-10       Impact factor: 4.335
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.